| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9316 |
| Human Intestinal Absorption | HIA+ | 0.9780 |
| Caco-2 Permeability | Caco2- | 0.6773 |
| P-glycoprotein Substrate | Non-substrate | 0.8423 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9875 |
| Non-inhibitor | 0.9962 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9536 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7260 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8648 |
| CYP450 2D6 Substrate | Non-substrate | 0.8898 |
| CYP450 3A4 Substrate | Non-substrate | 0.8207 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8715 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8588 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9538 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9455 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5076 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9882 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9726 |
| Non-inhibitor | 0.9827 |
| AMES Toxicity | AMES toxic | 0.5352 |
| Carcinogens | Carcinogens | 0.8177 |
| Fish Toxicity | High FHMT | 0.6212 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9480 |
| Honey Bee Toxicity | Low HBT | 0.5333 |
| Biodegradation | Ready biodegradable | 0.5000 |
| Acute Oral Toxicity | III | 0.3717 |
| Carcinogenicity (Three-class) | Non-required | 0.7047 |